Cubist Systematic Strategies’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,910
| Closed | -$25.3K | – | 2852 |
|
|
2024
Q1 | $25.3K | Buy |
+15,910
| New | +$25.3K | ﹤0.01% | 1984 |
|
|
2023
Q4 | – | Sell |
-34,089
| Closed | -$36.5K | – | 2780 |
|
|
2023
Q3 | $36.5K | Buy |
+34,089
| New | +$36.5K | ﹤0.01% | 1731 |
|
|
2023
Q2 | – | Sell |
-67,793
| Closed | -$277K | – | 3185 |
|
|
2023
Q1 | $277K | Sell |
67,793
-71,223
| -51% | -$291K | ﹤0.01% | 2075 |
|
|
2022
Q4 | $698K | Buy |
139,016
+64,018
| +85% | +$321K | ﹤0.01% | 1987 |
|
|
2022
Q3 | $981K | Sell |
74,998
-106,988
| -59% | -$1.4M | 0.01% | 2084 |
|
|
2022
Q2 | $2.33M | Buy |
181,986
+100,816
| +124% | +$1.29M | 0.01% | 1441 |
|
|
2022
Q1 | $1.24M | Buy |
81,170
+20,464
| +34% | +$312K | 0.01% | 1870 |
|
|
2021
Q4 | $1.08M | Buy |
60,706
+21,422
| +55% | +$379K | 0.01% | 1857 |
|
|
2021
Q3 | $826K | Buy |
39,284
+18,464
| +89% | +$388K | 0.01% | 1670 |
|
|
2021
Q2 | $411K | Buy |
20,820
+8,069
| +63% | +$159K | ﹤0.01% | 2134 |
|
|
2021
Q1 | $371K | Buy |
12,751
+10,821
| +561% | +$315K | ﹤0.01% | 2134 |
|
|
2020
Q4 | $58K | Sell |
1,930
-6,818
| -78% | -$205K | ﹤0.01% | 2455 |
|
|
2020
Q3 | $139K | Sell |
8,748
-8,516
| -49% | -$135K | ﹤0.01% | 2227 |
|
|
2020
Q2 | $341K | Buy |
17,264
+16,256
| +1,613% | +$321K | 0.01% | 1800 |
|
|
2020
Q1 | $12K | Buy |
+1,008
| New | +$12K | ﹤0.01% | 2085 |
|